The MYCN 5′ UTR as a therapeutic target in neuroblastoma
Authors:
Open Access
- 23 April 2024
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 43 (5) , 114134
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Alex's Lemonade Stand Foundation for Childhood Cancer
- National Institutes of Health
This publication has 69 references indexed in Scilit:
- Rapid 40S scanning and its regulation by mRNA structure during eukaryotic translation initiationCell, 2022
- Anota2seq Analysis for Transcriptome-Wide Studies of mRNA Translation2022
- Rocaglates Induce Gain-of-Function Alterations to eIF4A and eIF4FCell Reports, 2020
- PAR-CLIP: A Method for Transcriptome-Wide Identification of RNA Binding Protein Interaction Sites2016
- A Pipeline for PAR-CLIP Data Analysis2016
- CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven CancerCell, 2014
- Genome‐Wide Annotation and Quantitation of Translation by Ribosome ProfilingCurrent Protocols in Molecular Biology, 2013
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-EnhancersCell, 2013
- Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity GenesCell, 2013
- Stabilization of N-Myc Is a Critical Function of Aurora A in Human NeuroblastomaCancer Cell, 2009